Skip to main content
Clinical Trials/JPRN-UMIN000045800
JPRN-UMIN000045800
Completed
未知

Thrombosis and Anticoagulation Therapy in Patients with COVID-19 in Japan Study - CLOT-COVID Study

Fukushima Daiichi Hospital0 sites2,894 target enrollmentOctober 20, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Coronavirus disease 2019: COVID-19, severe acute respiratory syndrome coronavirus 2: SARS-CoV-2, Thrombosis
Sponsor
Fukushima Daiichi Hospital
Enrollment
2894
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In the present large-scale observational study, pharmacological thromboprophylaxis for hospitalized patients with COVID-19 was common especially in patients with severe COVID-19, and management strategies varied widely across the participating centers. The overall incidence of thrombosis was substantially low with an increased incidence according to the severity of the COVID-19.

Registry
who.int
Start Date
October 20, 2021
End Date
January 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fukushima Daiichi Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials